Gain Therapeutics shares owned by Springbok Capital Management
Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Springbok Capital Management
from 13F filings
Historical chart of Springbok Capital Management investment in Gain Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Gain Therapeutics held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Gain Therapeutics by Springbok Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $191k | 58k | 3.28 |
| 2023-06-30 | $260k | 58k | 4.48 |
| 2023-03-31 | $280k | 58k | 4.82 |
| 2022-12-31 | $182k | 58k | 3.13 |
| 2022-09-30 | $189k | 58k | 3.25 |
| 2022-06-30 | $209k | 58k | 3.60 |
| 2022-03-31 | $238k | 58k | 4.10 |
| 2021-12-31 | $315k | 58k | 5.42 |
| 2021-09-30 | $433k | 58k | 7.45 |
| 2021-06-30 | $581k | 58k | 10.00 |
| 2021-03-31 | $867k | 58k | 14.92 |
More positions owned by Springbok Capital Management
View all positions for Springbok Capital Management